Successful management of COVID-19 and associated coagulopathy in a patient with durable left ventricular assist device.
Kevin Edward HodgesMujtaba MubashirJoshua InslerJerry EstepEileen HsichMichael TongSteven InslerEdward SolteszPublished in: Journal of cardiac surgery (2020)
Patients with durable left ventricular assist devices pose special problems for management in the setting of COVID-19 infection. We describe the successful management of a 44-year-old man with severe COVID-19 infection and HeartMate 3 left ventricular assist device. His course was complicated by cytokine storm and COVID-19-associated coagulopathy. We describe our institutional protocol for managing COVID-19 infection in patients on mechanical circulatory support, focusing on the need for a thoughtful, multidisciplinary approach.
Keyphrases
- left ventricular assist device
- coronavirus disease
- sars cov
- end stage renal disease
- left ventricular
- chronic kidney disease
- ejection fraction
- randomized controlled trial
- heart failure
- mental health
- newly diagnosed
- peritoneal dialysis
- case report
- prognostic factors
- mitral valve
- acute coronary syndrome
- extracorporeal membrane oxygenation
- cardiac resynchronization therapy